Mercer Global Advisors
ATRS

Mercer Global Advisors’s Antares Pharma, Inc. ATRS Stock Holding History

Mercer Global Advisors’s Portfolio ATRS Stock Details ATRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-12,963
Closed -$46K – 1967
2021
Q4 		$46K Buy
+12,963
New +$45.3K ﹤0.01% 1759
2020
Q2 		– Sell
-51,216
Closed -$121K – 1207
2020
Q1 		$121K Sell
51,216
-4,481
-8% -$15.2K ﹤0.01% 997
2019
Q4 		$262K Buy
55,697
+10,225
+22% +$41.8K 0.01% 971
2019
Q3 		$152K Buy
45,472
+3,836
+9% +$12.6K ﹤0.01% 1048
2019
Q2 		$137K Buy
41,636
+1,013
+2% +$2.93K ﹤0.01% 1085
2019
Q1 		$123K Buy
+40,623
New +$132K ﹤0.01% 1014

Other funds holding ATRS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Amundi
Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
FWSM
First Wilshire Securities Management Pasadena, California $444M AUM 42.88% 1-Year Est. Return

Mercer Global Advisors's ATRS Position: Q1 2022 in Review

Mercer Global Advisors sold out of Antares Pharma, Inc. (ATRS) in Q1 2022, closing a stake of 12,963 shares — an estimated $46K sold.

Mercer Global Advisors first reported a position in ATRS in Q1 2019 and held it in 6 quarters. The position peaked at $262K in Q4 2019. 177 funds tracked by Wall St. Rank hold ATRS as of Q1 2022.

  • Mercer Global Advisors reported no remaining Antares Pharma, Inc. position as of Q1 2022 after selling out during the quarter.
  • Mercer Global Advisors sold 12,963 Antares Pharma, Inc. shares in Q1 2022, an estimated $46K.
  • Mercer Global Advisors first reported a position in Antares Pharma, Inc. in Q1 2019 and held it in 6 quarters.
  • Mercer Global Advisors's Antares Pharma, Inc. position peaked at $262K in Q4 2019.
  • 177 funds tracked by Wall St. Rank held Antares Pharma, Inc. as of Q1 2022.

Based on Mercer Global Advisors's 13F filing for Q1 2022, filed 10 May 2022.